NYSE American - Delayed Quote • USD
Xtant Medical Holdings, Inc. (XTNT)
At close: April 19 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.01 | -0.01 | -0.06 | 0 |
| Low Estimate | -0.02 | -0.02 | -0.06 | -0.01 |
| High Estimate | -0.01 | -0.01 | -0.06 | 0 |
| Year Ago EPS | -0.02 | -0.02 | 0.01 | -0.06 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 25.75M | 27.9M | 115M | 130.35M |
| Low Estimate | 24.6M | 26.8M | 114M | 126.1M |
| High Estimate | 26.9M | 29M | 116M | 134.6M |
| Year Ago Sales | 17.94M | 19.5M | 91.3M | 115M |
| Sales Growth (year/est) | 43.50% | 43.10% | 26.00% | 13.30% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.03 | -0.02 | -0.02 | -0.02 |
| EPS Actual | -0.02 | -0.02 | 0.07 | -0.03 |
| Difference | 0.01 | 0 | 0.09 | -0.01 |
| Surprise % | 33.30% | 0.00% | 450.00% | -50.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.01 | -0.01 | -0.06 | 0 |
| 7 Days Ago | -0.01 | -0.01 | -0.06 | 0 |
| 30 Days Ago | -0.01 | -0.01 | -0.05 | -0.01 |
| 60 Days Ago | -0.01 | -0.01 | -0.05 | -0.01 |
| 90 Days Ago | -0.01 | -0.01 | -0.05 | -0.01 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | XTNT | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 50.00% | -- | -- | 1.60% |
| Next Qtr. | 50.00% | -- | -- | 10.50% |
| Current Year | -700.00% | -- | -- | 5.20% |
| Next Year | 100.00% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 20.00% | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Initiated | BTIG: Buy | 12/5/2023 |
| Maintains | Craig-Hallum: Buy to Buy | 7/11/2023 |
| Initiated | Craig-Hallum: Buy | 4/26/2023 |
| Downgrade | Maxim Group: Buy to Hold | 5/17/2019 |
| Initiated | Maxim Group: Buy | 12/8/2016 |
| Initiated | Aegis Capital: Buy | 11/30/2016 |
Related Tickers
ATEC Alphatec Holdings, Inc.
12.54
+1.62%
CYDX CYduct Diagnostics, Inc.
0.3000
0.00%
BVS Bioventus Inc.
4.4800
-1.54%
OFIX Orthofix Medical Inc.
13.10
+0.61%
SNWV SANUWAVE Health, Inc.
0.0238
-0.42%
ECOR electroCore, Inc.
5.65
+0.18%
ELUT Elutia Inc.
2.9100
+0.34%
SRDX Surmodics, Inc.
26.49
+0.38%
SNN Smith & Nephew plc
23.84
-0.71%
VREX Varex Imaging Corporation
16.99
+0.41%